These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18588659)

  • 21. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.
    Anselmino M; Mellbin L; Wallander M; Rydén L
    Rev Cardiovasc Med; 2008; 9(1):29-38. PubMed ID: 18418307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome and cardiovascular disease: part 2.
    Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
    Kawano J; Arora R
    J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms.
    Gans RO
    Med Clin North Am; 2006 Jul; 90(4):573-91. PubMed ID: 16843763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A
    Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ; Tangchitnob EP; Lepor NE
    Rev Cardiovasc Med; 2009; 10(2):83-90. PubMed ID: 19593320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin Resistance and the cardiometabolic syndrome in HIV infection.
    Bevilacqua M; Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
    Abbasi F; Farin HM; Lamendola C; McGraw L; McLaughlin T; Reaven GM
    Metabolism; 2008 Aug; 57(8):1108-14. PubMed ID: 18640389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic syndrome: mechanisms, epidemiology, and clinical implications.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):17-27. PubMed ID: 19667650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromium in metabolic and cardiovascular disease.
    Hummel M; Standl E; Schnell O
    Horm Metab Res; 2007 Oct; 39(10):743-51. PubMed ID: 17952838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.